Evidence map›Paper›PMID 40568365›Full record

ArticleCase reports in endocrinology2025

Hyperparathyroidism-Jaw Tumor Syndrome Associated to a CDC73 Gene Pathogenic VARIANT and a Nonossifying Desmoplastic Fibroma of the Mandible.

Castellano Elena, Craparo Andrea, Fabrizia Di Giovanni, Linari Alessandra, Fortunato Mirella, Maffè Antonella

Abstract readCase Reports
In one paragraph

Article in Case reports in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A case report of desmoplastic fibroblastoma in a 2-year-old child.The Journal of international medical research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Castellano ElenaDepartment of Endocrinology, Diabetes and Metabolism, Santa Croce and Carle Hospital, Cuneo 12100, Italy.ORCID https://orcid.org/0000-0001-6622-4267
Craparo AndreaDepartment of Endocrinology, Diabetes and Metabolism, Santa Croce and Carle Hospital, Cuneo 12100, Italy.
Fabrizia Di GiovanniDivision of Pathology, Città della Salute Hospital, Torino 10100, Italy.
Linari AlessandraDivision of Pathology, Città della Salute Hospital, Torino 10100, Italy.
Fortunato MirellaDepartment of Pathology, Santa Croce and Carle Hospital, Cuneo 12100, Italy.
Maffè AntonellaGenetics and Molecular Biology Unit, Santa Croce and Carle Hospital, Cuneo 12100, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most cases of primary hyperparathyroidism (PHPT) are sporadic and are caused by parathyroid adenomas. Hereditary forms may occur in up to 10% of PHPT patients and are more frequent in younger patients. The hyperparathyroidism-jaw tumor (HPT-JT) syndrome is characterized by PHPT in up to 95% of patients and ossifying fibromas in the jaw in 25%-50%. We describe the case of a 35-year-old male from Bangladesh referred to our hospital due to a voluminous right mandibular swelling: a rare nonossifying fibroma of the mandible was diagnosed. Due to functional impotence, a left shoulder magnetic resonance imaging (MRI) was performed with evidence of a pluri-lobulated cyst-like lesion in the proximal humeral area diagnosed as a brown tumor (BT). Subsequent tests highlighted hypercalcemia and hypophosphatemia with high PTH levels. A heterozygous CDC73 pathogenic variant c.96>A p.Trp32Ter was identified. To the best of our knowledge, this is the first reported case of HPT-JT syndrome related to a CDC73 pathogenic variant, associated to a BT of the arm and a rare nonossifying fibroma of the mandible.

Indexed as

HPT-JT syndromeossifying fibromaPHPT

Identifiers

PMID40568365
PMCPMC12197466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.